J Korean Soc Matern Child Health.  2023 Apr;27(2):45-50. 10.21896/jksmch.2023.27.2.45.

Iron Deficiency Anemia in Pregnancy

• Yang SW
• Seo YS

• KMID: 2542185
• DOI: http://doi.org/10.21896/jksmch.2023.27.2.45

Abstract

Iron deficiency anemia (IDA) is the most common hematologic abnormality, which is a reduction in the concentration of erythrocytes or hemoglobin in the blood in pregnancy because Iron requirements increase during pregnancy. Since a failure to maintain sufficient levels of iron may result in adverse maternal-fetal consequences, active counseling and support from medical staff are necessary. Regarding the points to note during treatment, this document is to provide a brief overview of the IDA and medical management during pregnancy.

Keyword

Iron deficiency anemia; Pregnancy; Medical management

Reference

Achebe MM., Gafter-Gvili A. How I treat anemia in pregnancy: iron, cobalamin, and folate. Blood. 2017. 129:940–9.

Ahn TK., LI L., Lee SJ., Hu YH., Kim C., Hwang JY. Concentration in the early third trimester of pregnancy and risk of preterm birth and low birth weight based on gestational age. J Korean Soc Matern Child Health. 2021. 25:55–62.

American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics. Anemia in Pregnancy: ACOG Practice Bulletin, Number 233. Obstet Gynecol. 2021. 138:e55–64.

Bothwell TH. Overview and mechanisms of iron regulation. Nutr Rev. 1995. 53:237–45.

Carles G., Tobal N., Raynal P., Herault S., Beucher G., Marret H, et al. Doppler assessment of the fetal cerebral hemodynamic response to moderate or severe maternal anemia. Am J Obstet Gynecol. 2003. 188:794–9.

Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1998. 47(RR-3):1–29.

Cho JH., Ahn HS., Bae HS. The use of iron supplements of pregnant women and pregnancy outcome. Korean J Nutr. 2009. 14:327–39.

Earl R., Woteki CE; Institute of Medicine (US) Committee on the Prevention, Detection, and Management of Iron Deficiency Anemia Among U.S. Children and Women of Childbearing Age. Iron deficiency anemia: recommended guidelines for the prevention, detection, and management among U.S. children and women of childbearing age. Washington, DC: National Academy Press;1993.

FIGO Working Group on Good Clinical Practice in Maternal-Fetal Medicine. Good clinical practice advice: iron deficiency anemia in pregnancy. Int J Gynaecol Obstet. 2019. 144:322–4.

Govindappagari S., Burwick RM. Treatment of iron deficiency anemia in pregnancy with intravenous versus oral iron: systematic review and meta-analysis. Am J Perinatol. 2019. 36:366–76.

Hamstra RD., Block MH., Schocket AL. Intravenous iron dextran in clinical medicine. JAMA. 1980. 243:1726–31.

Harrison M. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Food and Nutrition Board. Nutrition during pregnancy and lactation: exploring new evidence: proceedings of a workshop. Washington (DC): National Academies Press (US);2020. Jul 31.

Jang HM., Ahn HS. Serum iron concentration of maternal and umbilical cord blood during pregnancy. Korean J Community Nutr. 2005. 10:860–8.

Kim HR., Lim HS. Iron intake during pregnancy on serum concentrations of trace minerals in mothers and neonates. Korean J Nutr. 2008. 41:242–53.

Kim SY. Iron deficiency anemia: diagnosis and treatment. Korean J Med. 2017. 92:155–61.

Lee HS., Kim MS., Kim MH., Kim YJ., Kim WY. Iron status and its association with pregnancy outcome in Korean pregnant women. Eur J Clin Nutr. 2006. 60:1130–5.

Lewkowitz AK., Gupta A., Simon L., Sabol BA., Stoll C., Cooke E, et al. Intravenous compared with oral iron for the treatment of iron-deficiency anemia in pregnancy: a systematic review and meta-analysis. J Perinatol. 2019. 39:519–32.

Litton E., Xiao J., Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ. 2013. 347:f4822.

Means RT. Iron deficiency and iron deficiency anemia: implications and impact in pregnancy, fetal development, and early childhood parameters. Nutrients. 2020. 12:447.

Milman N. Iron prophylaxis in pregnancy–general or individual and in which dose? Ann Hematol. 2006. 85:821–8.

Ontario Association of Medical Laboratories. Guidelines for the use of serum tests for iron deficiency (CLP 002). Toronto: OAML;2012.

Peace JM., Banayan JM. Anemia in pregnancy: pathophysiology, diagnosis, and treatment. Int Anesthesiol Clin. 2021. 59:15–21.

Peña-Rosas JP., De-Regil LM., Garcia-Casal MN., Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015. 2015:CD004736.

Rawal S., Hinkle SN., Bao W., Zhu Y., Grewal J., Albert PS, et al. A longitudinal study of iron status during pregnancy and the risk of gestational diabetes: findings from a prospective, multiracial cohort. Diabetologia. 2017. 60:249–57.

Rioux FM., LeBlanc CP. Iron supplementation during pregnancy: what. are the risks and benefits of current practices? Appl Physiol Nutr Metab. 2007. 32:282–8.

Royal College of Obstetricians & Gynaecologists. Blood transfusions in obstetrics (Green-top Guideline No. 47). London: Royal College of Obstetricians & Gynaecologists;2015.

Sherman SJ., Greenspoon JS., Nelson JM., Paul RH. Obstetric hemorrh-age and blood utilization. J Reprod Med. 1993. 38:929–34.

Sifakis S., Pharmakides G. Anemia in pregnancy. Ann N Y Acad Sci. 2000. 900:125–36.

Siu AL. U.S. Preventive Services Task Force. Screening for Iron Deficiency Anemia and Iron Supplementation in Pregnant Women to Improve Maternal Health and Birth Outcomes: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015. 163:529–36.

Sultan P., Bampoe S., Shah R., Guo N., Estes J., Stave C, et al. Oral vs intravenous iron therapy for postpartum anemia: a systematic review and meta-analysis. Am J Obstet Gynecol. 2019. 221:19–29e3.

Viteri FE., Berger J. Importance of pre-pregnancy and pregnancy iron status: can long-term weekly preventive iron and folic acid supplementation achieve desirable and safe status? Nutr Rev. 2005. 63(12 Pt 2):S65–76.

World Health Organization. Maternal, newborn, child and adolescent health and ageing [Internet]. Geneva (Switzerland): World Health Organization;2019. [cited 2023 Apr 1]. Available: https://www.who.int/data/maternal-newborn-child-adolescent-ageing/indicator-explorer-new/mca/prevalence-of-anaemia-in-pregnant-women-aged-15-49-years-(-)-(sdg-2.2.3) .

Wulff M., Ekström EC. Iron supplementation during pregnancy in Sweden: to what extent is the national recommendation followed? Acta Obstet Gynecol Scand. 2003. 82:628–35.

Wysowski DK., Swartz L., Borders-Hemphill BV., Goulding MR., Dor-mitzer C. Use of parenteral iron products and serious anaphylactic- type reactions. Am J Hematol. 2010. 85:650–4.